Nichols & Pratt Advisers LLP MA lifted its position in shares of Pfizer Inc. (NYSE:PFE – Get Rating) by 6.9% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 58,971 shares of the biopharmaceutical company’s stock after purchasing an additional 3,789 shares during the quarter. […]
Pinnacle Financial Partners Inc. grew its holdings in Pfizer Inc. (NYSE:PFE – Get Rating) by 6.2% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 394,148 shares of the biopharmaceutical company’s stock after acquiring an additional 23,173 shares during the period. Pinnacle […]
Fisher Asset Management LLC lessened its stake in shares of Pfizer Inc. (NYSE:PFE – Get Rating) by 4.9% in the 4th quarter, HoldingsChannel.com reports. The fund owned 1,955,743 shares of the biopharmaceutical company’s stock after selling 99,745 shares during the period. Fisher Asset Management LLC’s holdings in Pfizer were worth $100,212,000 as of its most […]
Hancock Whitney Corp raised its position in shares of Pfizer Inc. (NYSE:PFE – Get Rating) by 33.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 612,691 shares of the biopharmaceutical company’s stock after buying an additional 154,338 shares during the period. […]
American Express (NYSE:AXP) had its price target cut by JPMorgan Chase & Co. from $179.00 to $167.00 in a research note published on Monday, The Fly reports. They currently have a neutral rating on the payment services company’s stock. Several other analysts also recently commented on AXP. Robert W. Baird lifted their target price on […]